# Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer

> **NCT06713057** · PHASE2 · NOT_YET_RECRUITING · sponsor: **West China Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Locally Advanced Thyroid Gland Carcinoma
- Thyroid Cancer

## Interventions

- **DRUG:** Cyclophosphamide+Pemetrexed+5-Fluorouracil
- **DRUG:** Cyclophosphamide+Doxorubicin+5-Fluorouracil
- **DRUG:** Vindesine + Cisplatin
- **DRUG:** Doxorubicin + Cisplatin
- **DRUG:** Doxorubicin + Cyclophosphamide + Cisplatin
- **DRUG:** Docetaxel + Doxorubicin
- **DRUG:** Paclitaxel + Carboplatin
- **DRUG:** Paclitaxel + Doxorubicin
- **DRUG:** Paclitaxel + Cisplatin
- **DRUG:** Gemcitabine alone

## Key facts

- **NCT ID:** NCT06713057
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-07-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06713057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06713057, "Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT06713057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*